Quantcast

Latest Monoamine oxidase Stories

2014-03-04 16:17:56

NUS researchers create first highly sensitive small molecule fluorescence probe to evaluate potential risk for Parkinson's disease and monitor its progression A team of researchers from National University of Singapore (NUS) have created the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease. The highly sensitive fluorescence probe can detect with high precision the activity...

Warrior Gene Makes Women Happier
2012-08-29 05:33:28

April Flowers for redOrbit.com - Your Universe Online What is it that makes a woman happy?  Is it diamonds and furs, chocolate and wine, or a good book? No, apparently it's a gene. A new study from the University of South Florida (USF), the National Institutes for Health (NIH), Columbia University and the New York Psychiatric Institute has found a gene that appears to make women happy, but it doesn't work for men. The research team said this might explain why women are often...

2011-08-10 22:45:16

Mice without enzyme were also less inquisitive Do you run when you should stay? Are you afraid of all the wrong things? An enzyme deficiency might be to blame, reveals new research in mice by scientists at the University of Southern California. In a paper appearing in the October 2011 issue of the International Journal of Neuropharmacology, USC researchers show that mice lacking a certain enzyme due to genetic mutation are unable to properly assess threat. The mice exhibited defensive...

2011-08-02 14:00:20

Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown. This finding, which was published in the Archives of General Psychiatry, may also explain why heavy smokers are at high risk for clinical depression. Using an advanced brain imaging method, a team led by Senior Scientist Dr. Jeffrey Meyer discovered that MAO-A...

2011-01-06 06:30:00

RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2011 /PRNewswire/ -- CeNeRx BioPharma, Inc., today reported that it has initiated a Phase II trial of its new formulation of TriRima(TM), the company's novel antidepressant in development as monotherapy for treatment resistant depression. CeNeRx also announced that it will be presenting at Biotech Showcase(TM) 2011 on Tuesday, January 11, 2011 at 11:00 AM PST. TriRima is a member of a novel class of drugs known as RIMAs, or reversible and selective...

2010-11-30 07:00:00

BURLINGTON, Mass., Nov. 30, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, when comparing dopamine agonist use for Parkinson's disease, more frequent use of once-daily formulations of Requip (GlaxoSmithKline's Requip, Requip XL/LP/Modutab/RP/Prolib) and Mirapex (Boehringer Ingelheim's Mirapex/Sifrol/Mirapexin; Mirapex ER/Mirapexin ER/Sifrol Retard) occurs in France than in the remaining...

2010-11-02 06:30:00

RESEARCH TRIANGLE PARK, N.C., Nov. 2, 2010 /PRNewswire/ -- CeNeRx BioPharma, Inc., today announced that a new formulation of TriRima(TM), its lead agent for treatment resistant depression, showed excellent safety in a study designed to test whether it is free of the food-induced cardiovascular effects associated with conventional MAO inhibitors. These positive results further confirm the good safety profile demonstrated by TriRima in Phase I studies and set the stage for a TriRima...

2010-08-13 07:00:00

RESEARCH TRIANGLE PARK, N.C., Aug. 13 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds to conduct a Phase II trial of its improved formulation...

2010-05-04 13:36:18

Greater levels of a brain protein called monoamine oxidase A (MAO-A) "“ may explain why postpartum blues and clinical depression are so common after childbirth according to an important study published today in the Archives of General Psychiatry. Using an advanced brain imaging method, researchers at the Centre for Addiction and Mental Health discovered that levels of brain MAO-A in healthy women four to six days after delivery were 43% greater as compared to women not recently...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related